19 Nov 2020

COVID-19 vaccine: the top runners and riders

From Nine To Noon, 9:34 am on 19 November 2020
Pfizer and BioNTech Announce Successful First Interim Analysis of their COVID-19 Vaccine Candidate in Current Phase 3 Trial

Photo: AFP

The latest developments in the multiple candidates for a COVID-19 vaccine, with the University of Otago's Professor David Murdoch, a clinical microbiologist who's consulted for the WHO and the Health's Ministry Covid-19 Technical Advisory Group.

He's also been formally supporting the Oxford University COVID-19 vaccine development effort.

This follows promising results from two different vaccines ( one from Pfizer, the other Moderna) in as many weeks, which were both found to be highly effective in late stage trials.